Showing results (281-290 of 319) with videos related to
Sort By:
Pageof 32
Genetics in Medicine Open|January 16, 2026
An evaluation of genetic predisposition to congenital anomalies and pediatric cancer supports KAT6B as a novel neuroblastoma susceptibility geneHyunjung Gu, Yao Yu, Saumya Dushyant Sisoudiya, et al.Haematologica|January 22, 2026
Incidence and outcomes of treatment-associated hepatotoxicity during pediatric acute lymphoblastic leukemia induction therapy: a Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium reportAshley N Chavana, Emily J Mason, John P Woodhouse, et al.Journal of the National Cancer Institute|December 29, 2020
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology GroupHe Li, Saumya D Sisoudiya, Bailey A Martin-Giacalone, et al.Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.Cancer Epidemiology|February 19, 2019
Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International ConsortiumParaskevi Panagopoulou, Alkistis Skalkidou, Erin Marcotte, et al.Cancer Epidemiology|February 10, 2026
Associations of maternal education with suggested childhood cancer risk factors: Findings from the Childhood Cancer and Leukemia International Consortium (CLIC)Roya Dolatkhah, Friederike Erdmann, Liacine Bouaoun, et al.HGG Advances|June 11, 2025
The Impact of Genetic Ancestry on Survival Outcomes in Pediatric Rhabdomyosarcoma: A Report from the Children's Oncology GroupEkene A Onwuka, Christina L Magyar, Bailey A Martin-Giacalone, et al.Pharmacotherapy|December 30, 2024
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemiaRachel D Harris, Olga A Taylor, M Monica Gramatges, et al.Neuro-Oncology|November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.Journal of the National Cancer Institute|March 23, 2023
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology GroupBailey A Martin-Giacalone, Melissa A Richard, Michael E Scheurer, et al.Pageof 32